Conferences  >  Medicine & Healthcare  >  Oncology

Select a location
ALL COUNTRIES (39)
1
DKK2024 — 36. Deutscher Krebskongress 2024
21 Feb 2024 - 24 Feb 2024 • Berlin, Germany
Organizer:
Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe
Abstract:
Motto: Fortschritt gemeinsam gestalten

Der Kongress umfasst kompakte und intensive Bestandsaufnahme der aktuellen Forschungsergebnisse und Situation in der Onkologie in Deutschland.

Beleuchtet werden aktuelle und künftige medizinische Entwicklungen und neue Therapien für alle Tumorentitäten. Zudem Schwerpunkte und Fragen zur Gesundheitspolitik.

Contact:
Kongress- und Kulturmanagement GmbH
Event listing ID:
1560547
Related subject(s):
2
EASL Liver Cancer Summit 2024
22 Feb 2024 - 24 Feb 2024 • Rotterdam, Netherlands
Organizer:
The European Association for the Study of the Liver (EASL)
Abstract:
Focusing on primary liver tumors like hepatocellular carcinoma (HCC) and biliary tract cancer (BTC), the summit explores their connection to viral infections, alcohol misuse, and metabolic disorders among other fantastic programme highlights. Bringing together clinicians, researchers, nurses, patient advocates, and industry professionals, this summit aims to address these challenges in practice. By spotlighting recent insights into tumor origins and the latest in diagnostic and treatment strategies, the EASL Liver Cancer Summit 2024 aims to contribute significantly to the advancement of liver cancer care.
Event listing ID:
1587364
Related subject(s):
3
EACR-AACR-IACR 2024 Basic & Translational Research Conference: How to Bring Basic Science Discoveries to the Clinic
27 Feb 2024 - 29 Feb 2024 • Dublin, Ireland
Organizer:
European Association for Cancer Research (EACR) & American Association for Cancer Research (AACR), with support from the Irish Association for Cancer Research (IACR)
Abstract:
The EACR and AACR are proud to announce the 2024 edition of their joint Basic and Translational Research Conference, organised in conjunction with the IACR. The forum will highlight the latest cutting-edge advances in the understanding of the genomics, epigenetics, and molecular pathways involved in the development of pre-cancerous and cancerous lesions, and in cancer response to therapy. The scientific programme blends basic and translational research from preclinical models to patients. Topics include immunotherapy, cell-based therapies, novel/undruggable targets, drug combinations and resistance, the precancer genome, liquid biopsies, preclinical models, the tumour microenvironment, and epigenetics. The target audience is basic and translational scientists, experienced investigators and trainees at all levels with an interest in cancer development and treatment, and clinicians involved in the development of novel therapeutic approaches to treatment.
Contact:
Event organiser: New Way Management;     Email: eacr@newway-management.com
Topics:
NK cell immunity, CAR T cells, solid tumours, PML nuclear bodies, AML response to therapies, synergistic cancer drug combinations, immune contexture, immunoscore, carcinogenesis, Clonal Hematopoiesis (prevention of hematologic malignancies), Fanconi anemia, stem cell attrition, genomic instability, neoadjuvant immune checkpoint blockade, cancer liquid biopsies, MYC inhibitor, preclinical models for translational research, stromal heterogeneity and spatial distribution, cell plasticity, disease mechanisms in cancer, Polycomb Epigenetic Regulators, cancer research, oncology
Event listing ID:
1562482
4
HOFFM0524 — Hämato Onko Refresher Frankfurt
03 Mar 2024 - 04 Mar 2024 • Frankfurt, Germany
Organizer:
FomF GmbH - Forum für medizinische Fortbildung
Abstract:
Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Frankfurt & via Livestream,03.-04.05.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!
Contact:
Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de
Event listing ID:
1573935
5
IECC 2024 — The 4th International Electronic Conference on Cancers
06 Mar 2024 - 08 Mar 2024 • online, Singapore
Organizer:
MDPI
Abstract:
In recent years, we have witnessed remarkable breakthroughs in basic cancer research, where discoveries in the genetic and epigenetic tumor make-up and tumor microenvironment have provided valuable insights into the molecular mechanisms underlying cancer initiation, progression, and therapeutic response. This newfound knowledge has laid the groundwork for novel treatment strategies and personalized approaches that hold the potential to revolutionize cancer care. This conference aspires to bring together clinicians and scientists with diverse expertise and perspectives in cancer research to interact, exchange ideas, and form new collaborations that may lead to new advancements in scientific understanding and ultimately impact patient outcomes.
Contact:
Event Secretariat;     Email: iecc2024@mdpi.com
Topics:
Cancer Immunology and Immunotherapy, Cancer Biomarkers, Cancer Epidemiology and Prevention, Cancer Pathophysiology, Tumor Microenvironment, Transplant Oncology and Cancer Nursing Care, Cancer Therapy, Pediatric Oncology, Cancer Metastasis
Abstract submission deadline:
07 Nov 2023
Event listing ID:
1579997
6
ESMO Sarcoma and Rare Cancers Congress 2024
14 Mar 2024 - 16 Mar 2024 • Lugano, Switzerland
Organizer:
European Society for Medical Oncology (ESMO)
Abstract:
The congress will constitute an occasion for specialised physicians, oncologists, scientists, industry representatives, patient advocates and nurses, from all around the world, to connect, and share their knowledge, experience, and research for the advancement of treatment of sarcoma and rare cancers. The scientific and educational programme will feature insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers, including sessions on multidisciplinary expert management, targeted therapies, precision medicine, methodological challenges, policy and guidelines, as well as sessions specifically designed for young investigators.
Contact:
ESMO Meetings Operations Team;     Email: meetings@esmo.org
Topics:
sarcoma, rare cancers, drug development, molecular biology, oncology education, oncology congress, pathology, GIST, rare adult solid tumours, MDM2, desmoids
Event listing ID:
1586890
7
The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities
19 Mar 2024 - 21 Mar 2024 • Nottingham, United Kingdom
Organizer:
The European Association for Cancer Research (EACR)
Abstract:
This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy.

Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.

The target audience for this conference is: scientists, postdocs, and graduate students interested in multiple aspects of cancer biology, immunology, and therapeutics; industry scientists interested in translational research and novel therapeutic approaches; and journal editors interested in cutting-edge cancer biology.

Contact:
Conference Officer: Hannah Baars;     Email: hannah.barrs@eacr.org
Topics:
tumour ecosystem, carcinogenesis, metastasis, tumour therapy response, novel therapeutics, reciprocal cancer-stroma interactions, tumour progression, organ-specific stromal cells, tumour-host interactions, nervous system interactions, tumour dormancy, metastasis progression, ECM remodelling, therapy resistance, immune cell heterogeneity, stromal plasticity, immune plasticity, fibroblast interactions, treatment resistance, cancer research, oncology
Event listing ID:
1562738
8
The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities
19 Mar 2024 - 21 Mar 2024 • Bergamo, Italy
Organizer:
The European Association for Cancer Research
Abstract:
This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy. Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.
Contact:
Email: hannah.barrs@eacr.org
Topics:
tumour ecosystem, carcinogenesis, metastasis, tumour therapy response, novel therapeutics, reciprocal cancer-stroma interactions, tumour progression, organ-specific stromal cells, tumour-host interactions, nervous system interactions, tumour dormancy, metastasis progression, ECM remodelling, therapy resistance, immune cell heterogeneity, stromal plasticity, immune plasticity, fibroblast interactions, treatment resistance, cancer research, oncology
Event listing ID:
1562860
9
ITOC10 — 10th ImmunoTherapy of Cancer Conference
21 Mar 2024 - 24 Mar 2024 • Munich, Germany
Organizer:
ITOC is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Wolfgang Wilmanns Stiftung (WWS), the German Cancer Consortium (DKTK), the Chinese American Hematologist and Oncologist Network (
Abstract:
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Contact:
Event Secretariat;     Phone: [+431405138318];     Email: itoc@wma.co.at
Topics:
Basic Tumor Immunology, New Targets and New Leads, Exploiting B Cells and Other Cell Types, Microbiome, Adjuvant vs Neoadjuvant IO Treatment, Combination Therapies, Immuno-Monitoring, Reaching New Grounds in Cellular Therapies, Cell therapies in Hematologic Oncology, Cell Therapies in Solid Oncology
Event listing ID:
1585074
10
TWC 2024 — 7th Theranostics World Congress
22 Mar 2024 - 24 Mar 2024 • Santiago, Chile
Abstract:
The TWC is an international conference that brings together leading experts in the field from around the world. Our goal is to provide a platform for researchers, students, clinicians, and industry professionals to share their knowledge, learn and discuss the latest advancements in this exciting field.
Topics:
Theranostic, Radiomolecular Precision Medicine, RPM, Radioisotopes, Prostate Cancer, Radiotherapy, Tumor Microenvironment, NET, Radioisotopes, Congress
Event listing ID:
1572474
11
OeGHO- & AHOP-Frühjahrstagung 2024
04 Apr 2024 - 06 Apr 2024 • Vienna, Austria
Organizer:
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie
Abstract:
GEMEINSAM stärker – Stronger together ist das Thema unserer Frühjahrstagung 2024. Nicht nur die letzten Jahre haben unser Denken durch die COVID-Pandemie verändert. Auch schon davor hat sich immer klarer gezeigt, dass wir GEMEINSAM stärker sind. GEMEINSAM, was die Erforschung, das Behandeln und schließlich auch in immer mehr Fällen das Besiegen der Erkrankungbetrifft. GEMEINSAM ist hier ebenso interdisziplinär zu verstehen, und zwar über alle Berufsgruppen hinweg: dazu zählt die Pflege genauso wie die klinische Psychologie, die Studienkoordinator*innen, Grundlagenforschung und klinische Forschung, aber natürlich auch unsere Patient*innen.
Contact:
Sekretariat der OeGHO;     Email: office@oegho.at
Topics:
Frühjahrstagung, Hämatologie, Onkologie, OeGHO, AHOP
Event listing ID:
1569596
Related subject(s):
12
6TH INTERNATIONAL CANCER CONGRESS
16 Apr 2024 • Janakpurdham, Nepal
Organizer:
Binaytara foundation
Abstract:
The 2024 International Cancer Congress (ICC2024) is the 6th annual oncology conference organized by the Binaytara Foundation in Janakpurdham, Nepal. ICC2024 meeting will provide an opportunity to hear from the leading national and international experts on gastrointestinal malignancies and breast cancer.
Contact:
Phone: [425-616-0572];     Email: yoadan.h@binayfoundation.org
Topics:
Hematologists, Oncologists, Surgeons, Hematologic disorders, Breast cancer, oncology, patology
Event listing ID:
1583171
13
Precision Oncology Symposium — Miami Cancer Institute – Precision Oncology Symposium, Second Annual
19 Apr 2024 - 20 Apr 2024 • Miami Dade, United States
Organizer:
Baptist Health South Florida Continuing Medical Education
Abstract:
Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors - including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and, brain tumors by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.
Contact:
Phone: [17865963492];     Email: annab@baptisthealth.net
Topics:
Oncology, Precision, Baptist Health
Event listing ID:
1606895
14
Immuno-Oncology Summit Europe 2024
23 Apr 2024 - 25 Apr 2024 • London, United Kingdom
Organizer:
CHI
Abstract:
Now into our 8th year, CHI’s Immuno-Oncology Summit Europe is the premier event for immuno-oncology professionals who want to learn about the latest advancements and innovations in the field. The Summit will take place on 23-25 April 2024 in London, one of the world’s leading hubs for biomedical research and clinical development.
Event listing ID:
1606925
15
EMBO Workshop in-person meeting — Chromatin biology in cancer 2024
23 Apr 2024 - 26 Apr 2024 • Singapore, Singapore
Organizer:
European Molecular Biology Organization – EMBO
Event listing ID:
1578487
Related subject(s):
16
Personalized medicine in hepatobiliary malignancies
26 Apr 2024 - 27 Apr 2024 • Heidelberg, Germany
Organizer:
The European Association for the Study of the Liver (EASL)
Abstract:
After years of stagnation, a paradigm shift has occurred in the therapy of hepatobiliary malignancies: immune-oncology based combinations and new options in the second line revolutionized the treatment of patients with hepatocellular carcinoma, while biliary cancers – endowed with a genuinely high frequency of targetable lesions – evolved as a role model for precision oncology. These developments have generated a growing need for clinicians, pathologists and translational scientists to gain an in-depth understanding of diagnostic and clinical strategies that facilitate the implementation of individualized treatment concepts in hepato-oncology. The EASL school on “Personalized medicine in hepatobiliary malignancies” transitions fluently between molecular pathology diagnostics and clinical translation and provides room and space to foster interdisciplinary exchange. Under the guidance of experts in the field (liver pathologists, clinical and basic hepato-oncologists), students will gain confidence in the interpretation of molecular diagnostics reports and perform group work to build innovative treatment concepts for patients with hepatobiliary cancers. In addition to short lectures, panel discussions and a “live microscopy session”, the school features thought-provoking discourses on the diagnostic and therapeutic future of hepato-oncology.
Event listing ID:
1587389
Related subject(s):
17
EACR Cancer Multiomics & Computational Biology
30 Apr 2024 - 02 May 2024 • Bergamo, Italy
Organizer:
The European Association for Cancer Research
Abstract:
This revamped iteration of our renowned Cancer Genomics series will cover the latest exciting developments in the fields of genomics and bioinformatics including machine learning and AI, single-cell and spatial analysis of cancers, cell plasticity, cancer immunity genomics, data integration and convergence, epigenetics, and genomic instability. Featuring an exceptional international faculty, extensive networking opportunities and a limited number of in-person participants, this conference will provide both the possibility and intimate setting for top quality scientific interaction. We look forward to welcoming you to the Weizmann Institute of Science for this exciting meeting!
Contact:
Conference Officer: Chris Iliffe;     Email: christopher.iliffe@eacr.org
Topics:
multiomics, computational biology, machine learning, artificial intelligence, single-cell analysis, spatial analysis, cell plasticity, cancer immune genomics, data integration, data convergence, epigenetics, genomic instability, cancer immunology, molecular pathology, cancer transcriptomes, cell tracking, cancer evolution, immune evasion, the cancer genome, neoantigenic landscape, antitumour t-cell response, 3D analysis, translational research, cancer research, oncology
Abstract submission deadline:
26 Feb 2024
Event listing ID:
1573545
18
AMMF Hybrid 2024 European Cholangiocarcinoma Conference
08 May 2024 - 10 May 2024 • London, United Kingdom
Organizer:
AMMF
Abstract:
The annual AMMF cholangiocarcinoma (CCA) conference facilitates and encourages the sharing of information amongst interested medics in the UK, Europe and internationally. It provides an opportunity to find out about improvements in treatments, new and ongoing clinical trials, updates on research and encourages collaboration between researchers and medics. For 2024, AMMF is delighted to welcome Professor Shahid Khan and Professor Chiara Braconi, two internationally renowned specialists at the forefront of the CCA world, who will co-chair a conference dedicated to exploring the advances that are happening now. They will host a faculty of speakers selected from across the globe who will speak of the challenges faced and advances made in the understanding of CCA, and will discuss the importance of accelerating progress we are now seeing.
Topics:
cancer, liver cancer, hepatology, oncology, clinical trials, patient advocacy, gastroenterology, healthcare, treatments, therapies, diagnosis, bile duct cancer, cancer research, cholangiocarcinoma
Event listing ID:
1603616
Related subject(s):
19
Caring for Kids with Cancer Symposium
10 May 2024 • Miami, United States
Organizer:
Baptist Health South Florida
Abstract:
This symposium will focus on incorporating individual cancer genetic make-up with pathological diagnosis. The faculty — including leading experts from the top local and national cancer care institutions — will review the latest technologies and therapeutic approaches to challenging clinical problems, and will focus on evidence-based approaches to the special physical, emotional and psychological needs of pediatric cancer patients and their families.

Working in partnership to provide the best possible care for the communities they serve, two local leaders in healthcare – Miami Cancer Institute, part of Baptist Health South Florida, the area's largest, not-for-profit healthcare provider, and nonprofit Nicklaus Children's Hospital, part of Miami Children's Health System and the leading provider of children's healthcare services in South Florida – are collaborating to improve healthcare through continuing education.

Contact:
Phone: [786-596-2398];     Email: annab@baptisthealth.net
Topics:
Pediatric oncology conference, Kids with cancer conference, oncology conference
Event listing ID:
1606830
20
ESVONC Annual Congress 2024
23 May 2024 - 25 May 2024 • Bucharest, Hungary
Organizer:
European Society of Veterinary Oncology
Event listing ID:
1587198
Related subject(s):
21
International Conference on Cancer and Oncology Research
30 May 2024 - 31 May 2024 • Rome, Italy
Organizer:
Spectus Conferences
Abstract:
The Organizing Committee of International Conference on Cancer and Oncology Research invite you to participate in the Cancer Conference, which will be held during May 30-31, 2024 at Rome, Italy The main theme of conference is “Exploring the Recent Research and Advancements in Cancer and Oncology Research”. This Conference will provide a unique opportunity for researchers, healthcare practitioners, paramedics and trauma care specialists from around the world to communicate and share innovative thoughts and practices designed to optimize patient care.
Contact:
Phone: [03023084943];     Email: spec-cancer@spectusconferences.org
Topics:
Skin Cancers Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Cancer Therapy & Treatments Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Antibody-based Therapeutics Against Cancer Radiation Oncology
Event listing ID:
1585207
22
EACR2024 — EACR Congress 2024: Innovative Cancer Science
10 Jun 2024 - 13 Jun 2024 • Rotterdam, Netherlands
Organizer:
The European Association for Cancer Research
Abstract:
The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. The programme includes cutting-edge scientific talks on various topics, industry symposia and spotlights, educational sessions, meet-the-expert panels, career discovery sessions, and a vast poster display. Topics to be covered include: modulating the tumour microenvironment; drug resistance; mechanism-based clinical trials; precision cancer medicine in the post-genomic era; senescence, dormancy, and related cell states; metabolism and cancer; cell-based therapies; spatial analysis of tumours/spatial transcriptomics; mechanical forces of cancer; mechanisms of tumour metastases; targeting mitochondria in cancer; liquid biopsies; drugging tumour suppressor genes; imaging the tumour microenvironment; making cold tumours hot; drugging the RAS Pathway; modeling cancer; and aging, gender, and cancer.
Contact:
Event Organisers: New Way Management;     Email: eacr@newway-management.com
Topics:
cancer research, cancer research conference, oncology, cancer models, liquid biopsies, tumour microenvironment, tumour metastasis, cancer metabolism, cancer cell states, cell-based therapies, drug resistance, genomics, spatial transcriptomics
Event listing ID:
1583201
Event website:
23
DEGRO 2024 — 30th Congress of the German Society for Radiation Oncology
13 Jun 2024 - 15 Jun 2024 • Kassel, Germany
Organizer:
Deutsche Gesellschaft für Radioonkologie e.V. (German Society for Radiation Oncology)
Abstract:
At the annual congress of the German Society of Radiation Oncology (DEGRO), all those working in radiation oncology have the opportunity to discuss all aspects important for the development of radiation oncology in a concentrated form and thus come to a broad exchange of knowledge.
Contact:
Kongressorganisation;     Phone: [+49 3643 2468-126];     Email: degro-registrierung@KUKM.DE
Topics:
radiooncology, radiotherapy, nuclear medicine, oncology, radiology, radiation, hematology, medicine, nuclear physicians, medical technologist for radiology
Event listing ID:
1565871
24
HOHH0624 — Hämato Onko Refresher Hamburg
21 Jun 2024 - 22 Jun 2024 • Hamburg, Germany
Organizer:
FomF GmbH - Forum für medizinische Fortbildung
Abstract:
Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Hamburg & via Livestream, 21.-22.06.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!
Contact:
Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de
Event listing ID:
1573934
25
EACR Early-Career Researchers' Conference
25 Jun 2024 - 26 Jun 2024 • Online, Any Location (virtual event)
Organizer:
The European Association for Cancer Research
Abstract:
This highly interactive online meeting for early-career researchers focuses on career development. It will cover all the topics that our ECR members tell us they need – such as leadership skills, personal growth, translating research, and bridging the gap between academia and industry – and will offer plenty of opportunities for delegates to speak directly with the experts. The target audience for this conference is: scientists in the early phase of their career who want to develop a career in cancer research. The programme is tailored for scientists in the process of starting their independent path, as well as for researchers engaging with the clinical and industrial applications of their work.
Contact:
Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org
Topics:
cancer research, cancer research careers, oncology, oncology careers, career guidance, leadership skills, cancer research leadership, personal development, translating research, working in academia, working in industry, science sustainability, grant writing, science creativity, science diversity, personal brands, translational cancer research, basic cancer research, preclinical cancer research
Event listing ID:
1600205
Related subject(s):
26
ESMO GI 2024 — ESMO Congress on Gastrointestinal Cancers 2024
26 Jun 2024 - 29 Jun 2024 • Munich, Germany
Organizer:
European Society for Medical Oncology (ESMO)
Abstract:
Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present very impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern. The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Contact:
Phone: [+41 (0)91 973 19 62];     Email: gicongress@esmo.org
Topics:
Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Pancreatic Cancer, Biliary Tract Cancer, Neuroendocrine Tumors, Colon Cancer, Rectal Cancer, GIST, Anal Cancer, Gastrointestinal Cancers
Event listing ID:
1569554
27
11th ISCaM Meeting
03 Jul 2024 - 05 Jul 2024 • Brussels, Belgium
Abstract:
Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate under microenvironment- and therapy-induced stress conditions. Recent technical developments have revealed the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression. The 11th ISCaM meeting, in Brussels (Belgium), will gather renowned experts in the cancer metabolism field to discuss the most recent knowledge related to metabolic alterations in cancer, and how this can be translated to the clinics to treat cancer patients.
Topics:
Immunometabolism, Lipid metabolism and ferroptosis, Metabolism and therapy resistance, Tumor microenvironment and disease progression, Epigenetics, circadian clock and cancer metabolism, Tumor acidosis and imaging
Event listing ID:
1602446
Event website:
28
EMBO | FEBS Lecture Course — Molecular mechanisms in signal transduction and cancer
18 Aug 2024 - 26 Aug 2024 • Spetses, Greece
Organizer:
European Molecular Biology Organization – EMBO
Event listing ID:
1578704
Related subject(s):
29
The Mathematics of the Hallmarks of Cancer
19 Aug 2024 - 23 Aug 2024 • The Fields Institute, Toronto, Ontario, Canada
Organizer:
Fields Institute
Abstract:
This workshop aims to showcase the state-of-the-art mathematical and computational models that are in use in mathematical oncology, with a particular focus on the fourteen hallmarks of cancer. New modeling challenges arise from these hallmarks. Some of the hallmarks relate to the characteristics of the cancer cells themselves (sub-cellular and cellular level), while others include more global effects such as blood circulation, the immune response, the effect and role of the microenvironment, mechanical forces, and the microbiome. Matching the biological diversity of the cancer hallmarks, is the diversity of mathematical approaches and techniques that have been used and are in use to give insight into the growth and spread of cancer – for example, continuum and discrete models; ordinary and partial differential equation models; individual-based and agent-based models; hybrid models; deterministic and stochastic approaches; analytical and computational approaches. Many of these processes act on very different spatial and temporal scales. Hence a new integrated multiscale mathematical modeling framework is needed to include new aspects and insights, such as spatial stochastic models and local and non-local partial differential equation models.
Event listing ID:
1558114
30
ICPM10 & IWPCT9 — 10th International Conference on Plasma medicine and 9th International Workshop on plasma for cancer treatment
08 Sep 2024 - 13 Sep 2024 • Portorož, Slovenia
Organizer:
Jožef Stefan Institute
Abstract:
As in previous editions of the conference, the ICPM will bring together professionals from the fields of plasma, medicine, biology and biochemistry in order to develop a common language, to better define key challenges and open questions and to move toward effective solutions. This time it will be organized jointly with IWPCT covering plasma for cancer therapy on Monday, Sep. 9th. Prior to the conference, the traditional Summer School will take place, starting on the weekend, Sunday, Sep. 8th, and going through mornings from Monday, Sep. 9th to Wednesday, Sep. 11th. Registrations for the summer school will be conducted separately from the registrations for the conference.
Contact:
Email: icpm10@ijs.si
Topics:
plasma, medicine, cancer treatment,
Event listing ID:
1596867
Event website:
31
EHMSG 2024 — 37th Workshop of the European Helicobacter and Microbiota Study Group
12 Sep 2024 - 14 Sep 2024 • Porto, Portugal
Organizer:
European Helicobacter and Microbiota Study Group
Abstract:
The European Helicobacter and Microbiota Study Group (EHMSG) is a multidisciplinary group composed of representatives from most countries of the EU. It was founded in 1987 by a collaboration of pioneers in the field of Helicobacter and expanded its remit in 2016 to embrace the collective gastrointestinal microbiota. This includes dissemination of medical, scientific and technical information in order to promote health and decrease the burden of digestive diseases.

Each year, EHMSG hosts a conference consisting of a one-day postgraduate course followed by a 2-day workshop.

Contact:
Event Secretariat;     Phone: [+431405138318];     Email: workshop@ehmsg.org
Topics:
Helicobacter, Microbiota, IBD, FMT
Event listing ID:
1585035
32
Mathematical Modelling of Cancer Treatments, Resistance, Optimization
16 Sep 2024 - 20 Sep 2024 • The Fields Institute, Toronto, Ontario, Canada
Organizer:
Fields Institute
Abstract:
This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.
Event listing ID:
1558127
33
ADO 2024 — 34. Deutscher Hautkrebskongress
25 Sep 2024 - 28 Sep 2024 • Würzburg, Germany
Organizer:
Conventus Congressmanagement & Marketing GmbH
Contact:
Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de
Event listing ID:
1358745
Related subject(s):
34
The Ecology and Evolution of Cancer
30 Sep 2024 - 04 Oct 2024 • The Fields Institute, Toronto, Ontario, Canada
Organizer:
Fields Institute
Abstract:
This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .
Event listing ID:
1558062
35
EACR Cancer Metabolism
08 Oct 2024 - 10 Oct 2024 • Bilbao, Spain
Organizer:
The European Association for Cancer Research
Abstract:
This conference will gather top experts in the field of cancer metabolism to discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. Topics to be covered include: metabolic reprogramming in cancer beyond anabolism, metabolic transformation in cancer cells, metabolic signalling in cancer, metabolic cross-talk in the tumour microenvironment, metabolic regulation of gene expression, immune cell metabolism in cancer, nucleotide metabolism and cancer, metabolic approaches to cancer therapy, and systemic metabolic changes and their effects on cancer progression. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of cancer metabolism.
Contact:
Conference Officer: Chris Iliffe;     Phone: [N/A];     Email: christopher.iliffe@eacr.org
Topics:
cancer metabolism, adaptations of cancer, tumour biology, tumour vulnerabilities, cancer cell biology, stromal cell biology, metabolic cell wiring, cell anabolism, molecular properties of cancer cells, cancer genomics, cancer cell signalling, nutrient signalling, cancer metabolic alterations, metabolic cross-talk, the tumour microenvironment, the tumour macroenvironment, gene expression, immune cell metabolism, metabolic approaches to cancer therapy, cancer progression, cancer research, oncology
Abstract submission deadline:
05 Aug 2024
Event listing ID:
1600236
36
Mathematical Modelling of Tumour Immune Dynamics and Immunotherapies
14 Oct 2024 - 18 Oct 2024 • The Fields Institute, Toronto, Ontario, Canada
Organizer:
Fields Institute
Abstract:
Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.
Event listing ID:
1558107
37
EANO 2024 — 19th Meeting of the European Association of Neuro-Oncology
17 Oct 2024 - 20 Oct 2024 • Glasgow, United Kingdom
Abstract:
As usual, the annual EANO meeting will kick off with an Educational Day on Thursday, October 17 and the main programme will commence on Friday, October 18. The congress encourages exchange and collaboration between all relevant disciplines: Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals, and aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours. EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central nervous system. The successful 2023 EANO meeting in Rotterdam attracted more than 1000 participants from all continents and was very highly rated!
Event listing ID:
1602370
Related subject(s):
38
Oncology Research 2024 — 4th European Congress on Cancer and Oncology Research
28 Oct 2024 - 29 Oct 2024 • Rome, Italy
Organizer:
Coalesce Research Group
Abstract:
We are glad to announce the 4thEuropean Congress on Cancer and Oncology Research on October 28-29, 2024 at Rome, Italy with the theme “Breaking Barriers: Collaborative Approaches in Cancer Research”. Our Aim is to bring global scientists/ researchers and business professionals to one platform. Oncology Research 2024 includes the series of B2B & B2C meetings, Oral Talks, Poster Presentations, and Workshops & Exhibitions by Industries, Academicians, Professors, and Young Forum Researchers & Students.by providing collaboration spaces and break-out rooms with tea and lunch for speakers, and delegates between sessions with invaluable networking time for you.
Contact:
Phone: [1-718-543-9362];     Email: sarahlivingstone178@gmail.com
Topics:
Cells and Cell Structure Cancer Systems Biology Sarcoma Colorectal Cancer Breast-cancer Blood cancer Skin cancer Gynecologic Cancer Head and Neck Cancer Genetic Cancer Nanotechnology in cancer Organ Specific Cancer Pediatric Oncology Medical Oncology Radiation Oncology Neuro Oncology Tissue regeneration and Oncology Cancer Epidemiology Cancer Treatment & Therapy Covid & Its impact on cancer Cancer Immunotherapies Cancer Biomarkers Cancer Metastasis Cancer drugs Market Tumor Virology and Immunology Radiology and Medical Imaging Cancer Chemotherapy and Pharmacology
Event listing ID:
1593387
39
EACR Liquid Biopsies
12 Nov 2024 - 14 Nov 2024 • Lyon, France
Organizer:
The European Association for Cancer Research
Abstract:
Our popular Liquid Biopsies series returns for its fourth edition to bring together a slate of recognised experts who will explore how complex multi-modal liquid biopsy assays could be taken from the laboratory into clinical practice. Topics to be covered include the implementation of liquid biopsy in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multi-modal biomarkers, and how artificial intelligence can be applied to the field. This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals.
Contact:
Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org
Topics:
liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multi-modal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening
Event listing ID:
1600215


Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

No tracking | No pop-ups | No animations
Last updated: 12 February 2024